Ipca Labs appoints Dr Nagaji Ambabhai Vekariya as President - CRD
Ipca Labs has announced that Dr Nagaji Ambabhai Vekariya has joined the Company as President - CRD.
Dr Vekariya brings with him a professional experience of over 23 years. He started his career with Alembic Pharmaceuticals Ltd in the year 2001 and thereafter worked with companies like Glenmark Pharmaceuticals, Lupin Ltd, Aurobindo Pharma Ltd, Macleods Pharmaceuticals Ltd. & Neuland Laboratories Ltd.
Prior to joining Ipca, he was associated with Sekhmet Pharmaventures Pvt Ltd as Head - API & Formulations R&D.
Throughout his career, he has successfully led complex research initiatives, enabled global regulatory filings and played a pivotal role in advancing long term innovation strategies.
Dr Vekariya has completed his PhD in Organic Chemistry from Saurashtra University.
In March, the Medical Dialogues team reported that Ipca Labs appointed Saidutta Nanda as President - Human Resources.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.